Do we need a different set of response assessment criteria for tumor immunotherapy?
- PMID: 19934296
- DOI: 10.1158/1078-0432.CCR-09-2376
Do we need a different set of response assessment criteria for tumor immunotherapy?
Abstract
Tumor shrinkage induced by tumor immunotherapy may be preceded by inflammatory changes. This confounds the assessment of response rates to tumor immunotherapy. In this issue of Clinical Cancer Research, Wolchok et al. attempt to address this peculiarity by proposing a new set of criteria termed immune-related response criteria.
Comment on
-
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.Clin Cancer Res. 2009 Dec 1;15(23):7412-20. doi: 10.1158/1078-0432.CCR-09-1624. Epub 2009 Nov 24. Clin Cancer Res. 2009. PMID: 19934295 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources